Furthermore, SLC7A5 was associated with proliferation, invasion and migration of BLCA, which may not only accurately predict the clinical response of ICB, but also may be a new target for BLCA diagnosis and treatment. This evidence concerns the gene SLC7A5 and bladder transitional cell carcinoma.